Biopsies collected from patients with EOC and HCC revealed that tumor-infiltrating CD38+ immune cells were reduced and almost cleared by treatment [median (range), 22.5 (0-40) at baseline and 0 (0-1) at cycle 2 day 1; n = 8 (Figure 2)]. Here, CD38 is linked to hepatocellular carcinoma.